Gyre Therapeutics (GYRE)
NASDAQ:GYRE
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Financial Statements

803 Followers

Gyre Therapeutics Financial Overview

Gyre Therapeutics's market cap is currently ―. The company's EPS TTM is $-17.572; its P/E ratio is -0.87; Gyre Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 25.23M$ 27.17M-$ 29.33M$ 24.93M
Gross Profit$ 24.45M$ 26.19M-$ 28.25M$ 23.81M
EBIT$ 5.68M$ 12.15M$ -1.58M$ 5.60M$ 6.09M
EBITDA$ 5.92M$ 12.58M$ -1.58M$ 5.92M$ 6.37M
Net Income Common Stockholders$ 3.53M$ 7.53M$ -1.58M$ 1.85M$ 2.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.10M$ 37.35M$ 2.23M$ 6.92M$ 8.10M
Total Assets$ 120.93M$ 122.01M$ 9.96M$ 12.39M$ 18.75M
Total Debt$ 1.96M$ 275.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -23.14M$ -37.08M$ -2.23M$ -6.92M$ -8.10M
Total Liabilities$ 27.58M$ 33.24M$ 6.45M$ 7.40M$ 11.39M
Stockholders Equity$ 60.35M$ 56.64M$ 3.52M$ -28.31M$ -25.95M
Cash Flow-
Free Cash Flow$ -6.73M$ 2.70M$ -3.22M$ 2.17M$ 8.63M
Operating Cash Flow$ -5.49M$ 2.88M$ -3.22M$ 3.15M$ 11.80M
Investing Cash Flow$ -8.27M$ -7.22M-$ -6.71M$ -8.99M
Financing Cash Flow$ 156.00K$ 658.00K$ -1.48M$ -11.12M$ -141.82K
Currency in USD

Gyre Therapeutics Earnings and Revenue History

Gyre Therapeutics Debt to Assets

Gyre Therapeutics Cash Flow

Gyre Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis